Addressing Medicare Fraud in Skin Substitute Procedures

The Subcommittee on Health Care and Financial Services recently convened to address the alarming 7,100 percent surge in Medicare claims for skin substitute procedures. Subcommittee Chairman Glenn Grothman highlighted the urgent need to examine potential instances of fraud, waste, and abuse within Medicare's reimbursement framework. This meeting aimed to unravel the reasons behind such dramatic spending hikes and assess the effectiveness of recent reforms while identifying additional steps Congress and regulatory bodies could take to safeguard patient interests and foster responsible innovation.

Chairman Grothman pointed to federal investigations revealing significant fraud and abuse concerning skin substitutes, particularly in assisted living and skilled nursing facilities. Instances were uncovered where Medicare was billed for medically unnecessary procedures or services that were not delivered. The sharp increase in public spending, skyrocketing from $200 million in 2019 to $14.4 billion in 2025, has fueled concerns that current reimbursement practices might be inadvertently facilitating fraudulent activities by unscrupulous actors.

Efforts to combat this issue have included reimbursement reforms from the Centers for Medicare & Medicaid Services and enforcement actions by the Department of Justice. Despite these measures, ongoing concerns persist over safeguarding taxpayer funds and maintaining access to essential medical treatments. The roundtable aimed to dissect these fraud mechanisms, evaluate recent policy changes, and explore additional actions to strengthen Medicare’s regulatory compliance requirements, protecting both beneficiaries and healthcare providers. The involvement of diverse experts was expected to enrich the dialogue, offering insights that could inform potential policy advancements.